More earnings analysis: https://betafinch.com
Groups: RETAIL (https://betafinch.com/groups/RETAIL), INCOME (https://betafinch.com/groups/INCOME)
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. Today we're digging into Procter & Gamble's fiscal Q4 and full-year 2026 results — and there's a lot to unpack, from a CEO transition on the board to a fresh look at fiscal 2027 guidance.
But before we get into it, quick disclaimer. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.
JORDAN: Alright, so let's start with the news that isn't really about the numbers — Jon Moeller is retiring from the board after 38 years at P&G. He's held basically every top job there: CFO, COO, CEO, Executive Chairman. That's a long goodbye for someone who shaped the company's current structure.
ALEX: Right, and CEO Shailesh Jejurikar spent real time on the call thanking him before handing it to CFO Andre Schulten for the actual numbers. So let's get into those. For the full fiscal year, organic sales grew just over 1%, core EPS came in at $6.89, up about 1%. Not a blowout year, but they hit their guidance ranges despite what they called a "very volatile environment."
JORDAN: And that volatility really showed up in the fourth quarter specifically. Core EPS was $1.43, down 3% year-over-year — on a currency-neutral basis, down 5%. They pointed to a spike in energy, transportation, and material costs, about six cents a share, that was mostly offset by tariff refunds.
ALEX: There was also this interesting wrinkle in the U.S. business — a gap between what's called "sell out" versus "sell in." Basically, consumer purchases at retail — sell out — were up 2%, but P&G's shipments to retailers — sell in — were down 1%. That's a three-point gap.
JORDAN: Yeah, and management explained that pretty clearly — Amazon Prime Day shifted into late June this year instead of early July, which changed how promotional spending got recognized, plus retailers were drawing down inventory. It's a timing issue more than a demand issue, and honestly analysts pushed hard on this exact point during Q&A.
ALEX: They did. One analyst basically asked, "Is this a P&G-specific problem?" And Schulten's answer was pretty blunt — he said it's simply because P&G is bigger and has higher velocity than competitors, so when retailers want to cut inventory fast, they trim the biggest, fastest-moving brand on the shelf. It's math, not strategy failure.
JORDAN: What stood out to me geographically was China. Organic sales there grew 4% for both the quarter and the year, and P&G said they're growing share in China for the first time in 15 quarters. Baby care was the star — they highlighted this premium diaper using silk materials that's delivered double-digit growth for six straight quarters and now has them back as the number one baby care brand in the country.
ALEX: That silk diaper story is a nice example of their broader playbook — figure out what consumers actually want, translate it into product innovation, and let that drive both category growth and share. They gave a bunch of these: Vicks cough and cold in Latin America, Pantene in Germany leaning into influencer marketing, SK-II shifting to lifestyle content on social commerce.
JORDAN: The Tide story was probably my favorite, though. They did the biggest upgrade to original Tide liquid in over two decades — same price, much better performance — and it went from declining sales to high single-digit growth. Jejurikar said flat out it beat their own expectations.
ALEX: And that's really the "stronger core" half of their strategy — fix what you already have. The other half is "bigger more," which is Tide Evo, this new unit-dose detergent with no plastic packaging, built on over 50 patents. National rollout is h
This episode includes AI-generated content.
続きを読む
一部表示
2026/07/317 分